A Study to Evaluate the Safety and Efficacy of Using the Combination Treatment of SHR-1210, Gemcitabine and Cis-platinum by Recurrent and Metastatic NPC Subjects

Condition:   Nasopharyngeal Carcinoma
Interventions:   Biological: SHR-1210;   Drug: Gemcitabine;   Drug: cis-platinum
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting - verified April 2017

http://ift.tt/2oUAdvr